News
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
Faricimab (Vabysmo) showed greater fluid reduction compared with high-dose aflibercept (Eylea) at 12 weeks in matched analyses of diabetic macular edema (DME) and age-related macular degeneration (AMD ...
Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ...
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only FDA-approved treatment shown to ...
The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...
DelveInsight's Diabetic Macular Edema Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, January 13, 2025 /EINPresswire ...
The researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of diabetic macular edema (DME ... the group with CME and 25 in the group ...
High blood sugar can lead to eye problems like diabetic macular edema (DME), which affects the blood vessels in the back of your eye. When it's not treated, you could lose some or all of your sight.
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...
The findings of the ICMR-INDIAB study shed light on the significant impact of diabetes in India. The numbers reveal a staggering reality, with 101 million cases of diabetes (approx.1 in 14 people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results